Siemens Healthcare has announced that the U.S. Food and Drug Administration (FDA) has cleared its Artis Q and Artis Q.zen angiography system families, which feature revolutionary new X-ray tube and detector technology designed to improve minimally invasive therapy of diseases such as coronary artery disease (CAD), stroke and cancer. The new X-ray tube in both the Artis Q and Artis Q.zen can help physicians identify small vessels up to 70 percent better than conventional X-ray tube technology. The Artis Q.zen combines this X-ray source with a new detector technology that supports interventional imaging in ultra-low-dose ranges to patients, doctors and medical staff — particularly during longer interventions. With the Artis Q and Artis Q.zen system families, Siemens Healthcare again demonstrates its innovative strength and market competitiveness — key components of its Agenda 2013 two-year global Sector initiative.

Boston Scientific Corporation has begun the launch of its 0.035-inch and 0.018-inch Rubicon Support Catheter in the United States. The device is designed to assist physicians with placement and support of guidewires that are used in peripheral vascular procedures to deliver stents and balloons to open blockages in the legs and other peripheral arteries. Boston Scientific is also launching the 0.035-inch Rubicon Support Catheter in Europe to build on the momentum of the 0.018-inch size that was introduced in that region last fall.